Literature DB >> 19632366

Clinical and molecular overview of inherited disorders resulting from epigenomic dysregulation.

Albertina De Sario1.   

Abstract

Epigenetics is the study of heritable changes in gene expression that occur without a change in the DNA sequence. Most constitutional defects in genes encoding components of the machinery that regulates the epigenome lead to embryonic death. Hypomorphic mutations may be compatible with life, but lead to severe developmental disorders. Their study is of great importance to our understanding of epigenetics and may clarify the interplay between different epigenetic mechanisms. This review will briefly introduce DNA methylation, post-translational histone modifications, and non-coding small RNA transcription, which are the best known epigenetic mechanisms. Then it will describe five human disorders (RETT, ATRX, ICF, Coffin-Lowry, and Rubinstein-Taybi) resulting from mutations in genes responsible for DNA methylation and in genes involved in chromatin remodeling. Finally, it will discuss how research in medical genetics can elucidate fundamental epigenetic processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632366     DOI: 10.1016/j.ejmg.2009.07.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  7 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 2.  Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease.

Authors:  Jill S Butler; Evangelia Koutelou; Andria C Schibler; Sharon Y R Dent
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

3.  DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.

Authors:  Erica Lana; André Mégarbané; Hélène Tourrière; Pierre Sarda; Gérard Lefranc; Mireille Claustres; Albertina De Sario
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

4.  Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.

Authors:  Mark C Hannibal; Kati J Buckingham; Sarah B Ng; Jeffrey E Ming; Anita E Beck; Margaret J McMillin; Heidi I Gildersleeve; Abigail W Bigham; Holly K Tabor; Heather C Mefford; Joseph Cook; Koh-ichiro Yoshiura; Tadashi Matsumoto; Naomichi Matsumoto; Noriko Miyake; Hidefumi Tonoki; Kenji Naritomi; Tadashi Kaname; Toshiro Nagai; Hirofumi Ohashi; Kenji Kurosawa; Jia-Woei Hou; Tohru Ohta; Deshung Liang; Akira Sudo; Colleen A Morris; Siddharth Banka; Graeme C Black; Jill Clayton-Smith; Deborah A Nickerson; Elaine H Zackai; Tamim H Shaikh; Dian Donnai; Norio Niikawa; Jay Shendure; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2011-06-10       Impact factor: 2.802

5.  Severity of eating disorder symptoms related to oxytocin receptor polymorphisms in anorexia nervosa.

Authors:  Summer F Acevedo; Celeste Valencia; Michael Lutter; Carrie J McAdams
Journal:  Psychiatry Res       Date:  2015-06-11       Impact factor: 3.222

6.  Chromatin remodeling in development and disease: focus on CHD7.

Authors:  Donna M Martin
Journal:  PLoS Genet       Date:  2010-07-15       Impact factor: 5.917

Review 7.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.